Literature DB >> 26301229

Depressive symptoms in neurodegenerative diseases.

Miquel Baquero1, Nuria Martín1.   

Abstract

Depressive symptoms are very common in chronic conditions. This is true so for neurodegenerative diseases. A number of patients with cognitive decline and dementia due to Alzheimer's disease and related conditions like Parkinson's disease, Lewy body disease, vascular dementia, frontotemporal degeneration amongst other entities, experience depressive symptoms in greater or lesser grade at some point during the course of the illness. Depressive symptoms have a particular significance in neurological disorders, specially in neurodegenerative diseases, because brain, mind, behavior and mood relationship. A number of patients may develop depressive symptoms in early stages of the neurologic disease, occurring without clear presence of cognitive decline with only mild cognitive deterioration. Classically, depression constitutes a reliable diagnostic challenge in this setting. However, actually we can recognize and evaluate depressive, cognitive or motor symptoms of neurodegenerative disease in order to establish their clinical significance and to plan some therapeutic strategies. Depressive symptoms can appear also lately, when the neurodegenerative disease is fully developed. The presence of depression and other neuropsychiatric symptoms have a negative impact on the quality-of-life of patients and caregivers. Besides, patients with depressive symptoms also tend to further decrease function and reduce cognitive abilities and also uses to present more affected clinical status, compared with patients without depression. Depressive symptoms are treatable. Early detection of depressive symptoms is very important in patients with neurodegenerative disorders, in order to initiate the most adequate treatment. We review in this paper the main neurodegenerative diseases, focusing in depressive symptoms of each other entities and current recommendations of management and treatment.

Entities:  

Keywords:  Alzheimer; Dementia; Depression; Depressive symptoms; Frontotemporal degeneration; Lewy body disease; Neurodegenerative diseases; Vascular dementia

Year:  2015        PMID: 26301229      PMCID: PMC4539408          DOI: 10.12998/wjcc.v3.i8.682

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  126 in total

1.  Dementia Mood Assessment Scale.

Authors:  T Sunderland; M Minichiello
Journal:  Int Psychogeriatr       Date:  1996       Impact factor: 3.878

2.  Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity.

Authors:  S Andersson; J M Krogstad; A Finset
Journal:  Psychol Med       Date:  1999-03       Impact factor: 7.723

3.  Diagnostic criteria for apathy in clinical practice.

Authors:  E Mulin; E Leone; K Dujardin; M Delliaux; A Leentjens; F Nobili; B Dessi; O Tible; L Agüera-Ortiz; R S Osorio; J Yessavage; D Dachevsky; F R J Verhey; Alfonso J Cruz Jentoft; O Blanc; P M Llorca; P H Robert
Journal:  Int J Geriatr Psychiatry       Date:  2011-02       Impact factor: 3.485

Review 4.  Cognitive dysfunction in unipolar depression: implications for treatment.

Authors:  Madhukar H Trivedi; Tracy L Greer
Journal:  J Affect Disord       Date:  2013-09-25       Impact factor: 4.839

5.  Suicide risk in Huntington's disease.

Authors:  L Di Maio; F Squitieri; G Napolitano; G Campanella; J A Trofatter; P M Conneally
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

6.  Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia.

Authors:  Manuel Fernández-Martínez; Jessica Castro; Ana Molano; Juan José Zarranz; Rosa Monica Rodrigo; Rafael Ortega
Journal:  Curr Alzheimer Res       Date:  2008-02       Impact factor: 3.498

7.  The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Authors:  C Holmes; D Wilkinson; C Dean; S Vethanayagam; S Olivieri; A Langley; N D Pandita-Gunawardena; F Hogg; C Clare; J Damms
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

8.  Psychopathology of very mild dementia of the Alzheimer type.

Authors:  E H Rubin; D A Kinscherf
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

9.  The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.

Authors:  Florindo Stella; Orestes Vicente Forlenza; Jerson Laks; Larissa Pires de Andrade; Michelle A Ljubetic Avendaño; Elisandra Villela Gasparetto Sé; João de Castilho Cação; Constantine G Lyketsos; Kate de Medeiros
Journal:  Int Psychogeriatr       Date:  2013-06-14       Impact factor: 3.878

10.  Behavioural and psychological symptoms in poststroke vascular cognitive impairment.

Authors:  Meena Gupta; Abhijit Dasgupta; Geeta Anjum Khwaja; Debashish Chowdhury; Yogesh Patidar; Amit Batra
Journal:  Behav Neurol       Date:  2014-03-02       Impact factor: 3.342

View more
  32 in total

Review 1.  Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.

Authors:  Yanwei Li; Lin Li; Christian Hölscher
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

2.  The association of anxio-depressive disorders and depression with motoric cognitive risk syndrome: results from the baseline assessment of the Canadian longitudinal study on aging.

Authors:  Harmehr Sekhon; Gilles Allali; Olivier Beauchet
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

3.  Association of Midlife Diet With Subsequent Risk for Dementia.

Authors:  Tasnime N Akbaraly; Archana Singh-Manoux; Aline Dugravot; Eric J Brunner; Mika Kivimäki; Séverine Sabia
Journal:  JAMA       Date:  2019-03-12       Impact factor: 56.272

Review 4.  Roles of Fatty Acids in Microglial Polarization: Evidence from In Vitro and In Vivo Studies on Neurodegenerative Diseases.

Authors:  Miey Park; Hae-Jeung Lee
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 5.  Neurotoxicity of e-cigarettes.

Authors:  Joanna A Ruszkiewicz; Ziyan Zhang; Filipe Marques Gonçalves; Yousef Tizabi; Judith T Zelikoff; Michael Aschner
Journal:  Food Chem Toxicol       Date:  2020-03-05       Impact factor: 6.023

6.  Depression and Related Factors in Patients with Parkinson's Disease at High Altitude.

Authors:  Yu Cao; Gongfeng Li; Jinsheng Xue; Guijuan Zhang; Sensen Gao; Yuling Huang; Aiqin Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-06       Impact factor: 2.570

7.  Longitudinal Relationships Between Subjective Cognitive Decline and Objective Memory: Depressive Symptoms Mediate Between-Person Associations.

Authors:  Nikki L Hill; Sakshi Bhargava; Emily Bratlee-Whitaker; Jennifer R Turner; Monique J Brown; Jacqueline Mogle
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.

Authors:  Zanna J Voysey; Roger A Barker; Alpar S Lazar
Journal:  Neurotherapeutics       Date:  2020-11-11       Impact factor: 7.620

9.  Diagnostic value of amygdala volume on structural magnetic resonance imaging in Alzheimer's disease.

Authors:  De-Wei Wang; Shou-Luan Ding; Xian-Li Bian; Shi-Yue Zhou; Hui Yang; Ping Wang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

Review 10.  Depression in Parkinson's Disease: The Contribution from Animal Studies.

Authors:  Jéssica Lopes Fontoura; Camila Baptista; Flávia de Brito Pedroso; José Augusto Pochapski; Edmar Miyoshi; Marcelo Machado Ferro
Journal:  Parkinsons Dis       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.